Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Bladder Cancer

Free Subscription Articles published in Int J Oncol Retrieve available abstracts of 17 articles: HTML format Text format

Single Articles

January 2012
1. MIZUTANI Y , Katsuoka Y, Bonavida B
   Low circulating serum levels of second mitochondria-derived activator of caspase (Smac/DIABLO) in patients with bladder cancer.
   Int J Oncol. 2012 Jan 3. doi: 10.3892/ijo.2012.1324.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
2. TATARANO S , Chiyomaru T, Kawakami K, Enokida H, et al
   Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.
   Int J Oncol. 2011 Dec 13. doi: 10.3892/ijo.2011.1294.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. WATSON CJ , O'Kane H, Maxwell P, Sharaf O, et al
   Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer.
   Int J Oncol. 2011 Nov 4. doi: 10.3892/ijo.2011.1250.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
4. HSU SC , Yu CC, Yang JS, Lai KC, et al
   A novel synthetic 2-(3-methoxyphenyl)-6,7-methylenedioxoquinolin-4-one arrests the G2/M phase arrest via Cdc25c and induces apoptosis through caspase- and mitochondria-dependent pathways in TSGH8301 human bladder cancer cells.
   Int J Oncol. 2011 Oct 21. doi: 10.3892/ijo.2011.1241.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
5. MARCINKIEWICZ K , Scotland KB, Boorjian SA, Nilsson EM, et al
   The androgen receptor and stem cell pathways in prostate and bladder cancers (Review).
   Int J Oncol. 2011 Sep 28. doi: 10.3892/ijo.2011.1212.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
6. MOIBI JA , Mak AL, Sun B, Moore RB, et al
   Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL.
   Int J Oncol. 2011;39:61-71.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   June 2011
7. VASSOU D , Notas G, Hatzoglou A, Castanas E, et al
   Opioids increase bladder cancer cell migration via bradykinin B2 receptors.
   Int J Oncol. 2011 Jun 3. doi: 10.3892/ijo.2011.1063.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   May 2011
8. TADA Y , Yokomizo A, Shiota M, Tsunoda T, et al
   Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer.
   Int J Oncol. 2011 May 23. doi: 10.3892/ijo.2011.1049.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2011
9. TATARANO S , Chiyomaru T, Kawakami K, Enokida H, et al
   miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.
   Int J Oncol. 2011 Apr 20. doi: 10.3892/ijo.2011.1012.
   PubMed     Text format     Related articles   
   
   
   
   
10. KIM CJ , Sakamoto K, Tambe Y, Inoue H, et al
    Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells.
    Int J Oncol. 2011 Apr 5. doi: 10.3892/ijo.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
11. YANO K , Horinaka M, Yoshida T, Yasuda T, et al
    Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
    Int J Oncol. 2011;38:365-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
12. AZUMA H , Inamoto T, Ibuki N, Ubai T, et al
    Utility of the novel bladder preservation therapy, BOAI-CDDP-radiation (OMC-regimen), for elderly patients with invasive bladder cancer.
    Int J Oncol. 2011;38:13-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
13. TOKI K , Enokida H, Kawakami K, Chiyomaru T, et al
    CpG hypermethylation of cellular retinol-binding protein 1 contributes to cell proliferation and migration in bladder cancer.
    Int J Oncol. 2010;37:1379-88.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
14. KUO JH , Chu YL, Yang JS, Lin JP, et al
    Cantharidin induces apoptosis in human bladder cancer TSGH 8301 cells through mitochondria-dependent signal pathways.
    Int J Oncol. 2010;37:1243-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
15. AZUMA H , Inamoto T, Ibuki N, Ubai T, et al
    Novel bladder preservation therapy for locally invasive bladder cancer: Combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
    Int J Oncol. 2010;37:773-85.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
16. MIZUTANI Y , Katsuoka Y, Bonavida B
    Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy.
    Int J Oncol. 2010;37:503-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
17. HUANG YT , Lai PC, Wu CC, Hsu SH, et al
    BDNF mediated TrkB activation is a survival signal for transitional cell carcinoma cells.
    Int J Oncol. 2010;36:1469-76.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: